The IPO Buzz: Actuate Therapeutics (ACTU) Pops in NASDAQ Debut
Shares of small-cap pancreatic cancer biotech Actuate Therapeutics (ACTU) shot up 23.5 percent to open at $9.88 at 10:45 a.m. EDT today – Tuesday, Aug. 13, 2024 – up $1.88 from the $8.00 IPO price – in their NASDAQ trading debut. Volume was 8,894 shares on that opening trade, according to NASDAQ records. At the […]
August 13, 2024 Read More